US EditionAAX Biotech announces collaboration for cardiovascular antibody therapy - Pharmafile
Summary by pharmafile.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
AAX Biotech announces collaboration for cardiovascular antibody therapy - Pharmafile
Swedish biotech firm AAX Biotech has entered a new collaboration focused on the development of antibody-based therapies targeting cardiovascular disease. As part of the agreement, AAX Biotech will apply its proprietary Seqitope technology to support the clinical development of an antibody currently undergoing trials. The technology offers high-resolution epitope mapping, which provides detailed insight into […] The post AAX Biotech announces col…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
